BASSO CAPITAL MANAGEMENT, L.P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 38 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BASSO CAPITAL MANAGEMENT, L.P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2022$755,000
+0.1%
74,9610.0%0.08%
+9.7%
Q1 2022$754,000
-0.3%
74,9610.0%0.07%
-13.3%
Q4 2021$756,00074,9610.08%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,261,0000.86%
Wealthspring Capital LLC 263,040$2,653,0000.57%
Bulldog Investors, LLP 122,600$1,237,0000.33%
Context Capital Management, LLC 400,000$4,036,0000.32%
MMCAP International Inc. SPC 500,000$5,045,0000.31%
HGC Investment Management Inc. 500,000$5,045,0000.31%
Sage Rock Capital Management LP 184,000$1,857,0000.28%
Lynwood Capital Management Inc. 25,000$252,0000.24%
Castle Creek Arbitrage, LLC 400,000$4,036,0000.20%
Shaolin Capital Management LLC 750,000$7,568,0000.20%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders